StemRIM (TSE:4599) ROE % Adjusted to Book Value: -9.66% (As of Jan. 2026)


TSE:4599 StemRIM Inc TSE:4599
34 GF Score
Price 円313.00
! 2 Warning Signs
View Full Analysis

What is StemRIM ROE % Adjusted to Book Value?

StemRIM TSE:4599 +0.97% 34 ROE % Adjusted to Book Value is -9.66% as of Jan. 2026. GuruFocus rates TSE:4599 with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

StemRIM's ROE % for the quarter that ended in Jan. 2026 was -26.75%. StemRIM's PB Ratio for the quarter that ended in Jan. 2026 was 2.77. StemRIM's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2026 was -9.66%.

StemRIM ROE % Adjusted to Book Value Related Terms

StemRIM ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for StemRIM's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

StemRIM ROE % Adjusted to Book Value Chart

StemRIM Annual Data
Trend Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only -1.48 -3.65 0.31 -6.75 -8.82

StemRIM Semi-Annual Data
Jul17 Jul18 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25 Jan26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.79 -6.99 -10.21 -8.43 -9.66

TSE:4599 vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, StemRIM's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

StemRIM ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemRIM's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where StemRIM's ROE % Adjusted to Book Value falls into.


TSE:4599
34GF Score
StemRIM Inc TSE:4599
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

StemRIM ROE % Adjusted to Book Value Calculation

StemRIM's ROE % Adjusted to Book Value for the fiscal year that ended in Jul. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-23.81% / 2.70
=-8.82%

StemRIM's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-26.75% / 2.77
=-9.66%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -9.66% mean?
StemRIM (TSE:4599) has a ROE % Adjusted to Book Value of -9.66% as of Jan. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on StemRIM and its competitors.
Is StemRIM's ROE % Adjusted to Book Value too high?
StemRIM's current ROE % Adjusted to Book Value is -9.66%. Overall, StemRIM has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does StemRIM's ROE % Adjusted to Book Value compare to VRTX and REGN?
StemRIM's ROE % Adjusted to Book Value of -9.66% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on StemRIM and its competitors. StemRIM's current ROE % Adjusted to Book Value is -9.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is StemRIM stock overvalued right now?
StemRIM (TSE:4599) has a current ROE % Adjusted to Book Value of -9.66%. The current ROE % Adjusted to Book Value is -9.66%. StemRIM's overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For StemRIM (TSE:4599), the current ROE % Adjusted to Book Value is -9.66% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

StemRIM Business Description

Address 7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085
StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.
34GF Score

Get the complete analysis for TSE:4599

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円313.00
Price